https://www.selleckchem.com/products/skf96365.html
Serum biomarkers associated with the severity of non-cystic fibrosis (CF) bronchiectasis are insufficient. This study determined the association of serum hepatocyte growth factor (HGF), osteopontin, and pentraxin-3 levels with disease severity and exacerbation in patients with non-CF bronchiectasis. Serum levels of HGF, osteopontin, and pentraxin-3 were measured in patients with clinically stable non-CF bronchiectasis (n=61). The correlation between the biomarkers and bronchiectasis severity index (BSI) and FACED score was assessed usi
Aimer
Commentaire
Partagez
